Corindus Vascular Robotics, Revenue Growth Rates (CVRS), Current and Historic Growth - CSIMarket
CSIMarket
 


Corindus Vascular Robotics, Inc.  (CVRS)
 

CVRS's Revenue Growth by Quarter and Year

Corindus Vascular Robotics,'s Revenue results by quarter and year




CVRS Revenue (in millions $) FY 2019 FY 2018 FY 2017 FY 2016
4th Quarter December -
3rd Quarter September -
2nd Quarter June 4.58
1st Quarter March 3.04
FY 7.62

CVRSs Annual Revenue
Corindus Vascular Robotics,'s Revenue in the fiscal year 2018 $ 10.78 millions
Corindus Vascular Robotics,'s Revenue in the fiscal year 2017 $ 9.65 millions
Corindus Vascular Robotics,'s Revenue in the fiscal year 2016 $ 2.84 millions
Corindus Vascular Robotics,'s Revenue in the fiscal year 2015 $ 2.73 millions
Corindus Vascular Robotics,'s Revenue in the fiscal year 2014 $ 2.98 millions




CVRS Revenue second quarter 2019 Y/Y Growth Comment
Corindus Vascular Robotics, Inc. reported Revenue surge of 173.95% year on year in the second quarter 2019, to $ 4.58 millions, this is lower than Corindus Vascular Robotics, Inc.'s recent average Revenue surge of 1531.54%.

Looking into second quarter 2019 results within Medical Equipment & Supplies industry 14 other companies have achieved higher Revenue growth. While Corindus Vascular Robotics, Inc.' s Revenue doubling of 173.95% ranks overall at the positon no. 192 in the second quarter 2019.




CVRS Revenue ( Y/Y Growth %) 2019
2018 2017 2016
4th Quarter December - 11.46 % 675.93 % -34.94 %
3rd Quarter September - 21.81 % 252.17 % 228.57 %
2nd Quarter June 173.95 % -26.11 % 343.14 % -43.96 %
1st Quarter March 104.03 % 91.03 % -29.73 % 42.31 %
FY   - 11.7 % 238.95 % -

Financial Statements
Corindus Vascular Robotics,'s second quarter 2019 Revenue $ 4.58 millions CVRS's Income Statement
Corindus Vascular Robotics,'s second quarter 2018 Revenue $ 1.67 millions Quarterly CVRS's Income Statement


CVRS Revenue (Quarter on Quarter Growth %)

2019
2018 2017 2016
4th Quarter December - 57.77 % 72.43 % -21.74 %
3rd Quarter September - 77.25 % 7.52 % 35.29 %
2nd Quarter June 50.49 % 12.08 % 189.74 % -54.05 %
1st Quarter March -34.9 % -64.44 % 44.44 % 33.73 %
FY (Year on Year)   - 11.7 % 238.95 % -




Revenue second quarter 2019 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #15
Healthcare Sector #64
Overall #192

Revenue Y/Y Growth Statistics
High Average Low
22000.66 % 1531.54 % -92.87 %
(Dec 31 2014)   (Mar 31 2015)
Revenue second quarter 2019 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #15
Healthcare Sector #64
Overall #192
Revenue Y/Y Growth Statistics
High Average Low
22000.66 % 1531.54 % -92.87 %
(Dec 31 2014)   (Mar 31 2015)

Revenue by Quarter for the Fiscal Years 2016, 2017, 2018, 2019

Corindus Vascular Robotics,'s Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
74672.77 % 4225.58 % -99.86 %
(Mar 31 2014)  


CVRS's II. Quarter Q/Q Revenue Comment
Corindus Vascular Robotics, Inc. achieved in the II. Quarter 2019 below company average Revenue jump of 50.49% quarter on quarter, to $ 4.58 millions.

Although the II. Quarter 2019 Revenue Q/Q growth was lower than the regular , this has been yet encouraging story, as the II. Quarter surge, eclipses the 12.08% growth in the II. Quarter a year ago

Within Medical Equipment & Supplies industry 14 other companies have achieved higher Revenue quarter on quarter growth. While Corindus Vascular Robotics,'s Revenue growth quarter on quarter, overall rank is 320.


Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #15
Healthcare Sector #83
Overall #320
Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #15
Healthcare Sector #83
Overall #320
Revenue Q/Q Growth Statistics
High Average Low
74672.77 % 4225.58 % -99.86 %
(Mar 31 2014)  


CVRS's II. Quarter Q/Q Revenue Comment
Corindus Vascular Robotics, Inc. achieved in the II. Quarter 2019 below company average Revenue jump of 50.49% quarter on quarter, to $ 4.58 millions.

II. Quarter 2019 Revenue Q/Q growth were paradoxical, although lower than the regular, yet it demonstrates absolute recovery measured to the 12.08% in the II. Quarter a year ago.

Within Medical Equipment & Supplies industry 14 other companies have achieved higher Revenue quarter on quarter growth. While Corindus Vascular Robotics,'s Revenue growth quarter on quarter, overall rank is 320.


Corindus Vascular Robotics,'s 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Jun 30 2019)
12 Months Ending
(Mar 31 2019)
12 Months Ending
(Dec 31 2018)
12 Months Ending
(Sep 30 2018)
12 Months Ending
(Jun 30 2018)
Cumulative Revenue 12 Months Ending $ 15.24 $ 12.33 $ 10.78 $ 10.30 $ 9.77
Y / Y Revenue Growth (TTM) 56.09 % 19.06 % 11.72 % 71.69 % 129.17 %
Year on Year Revenue Growth Overall Ranking # 128 # 272 # 87 # 101 # 0
Seqeuential Revenue Change (TTM) 23.6 % 14.39 % 4.69 % 5.46 % -5.73 %
Seq. Revenue Growth (TTM) Overall Ranking # 1242 # 201 # 269 # 146 # 0


Cumulative Revenue growth Comment
Although Corindus Vascular Robotics,'s Annual Revenue growth year on year were below company's average 211.08% , Revenue announced in the Jun 30 2019 period, show improvement in Revenue trend, to cumulative trailing twelve month growth of 56.09% year on year, from 19.06% in Mar 31 2019.

In the Healthcare sector 39 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 128, from total ranking in previous quarter at 272.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 56
Healthcare Sector # 40
Overall # 128

Revenue TTM Y/Y Growth Statistics
High Average Low
3023.07 %
211.08 %
-53.71 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 56
Sector # 233
S&P 500 # 1242
Cumulative Revenue growth Comment
Although Corindus Vascular Robotics,'s Annual Revenue growth year on year were below company's average 211.08% , Revenue announced in the Jun 30 2019 period, show improvement in Revenue trend, to cumulative trailing twelve month growth of 56.09% year on year, from 19.06% in Mar 31 2019.

In the Healthcare sector 39 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 128, from total ranking in previous quarter at 272.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 56
Healthcare Sector # 40
Overall # 128

Revenue TTM Y/Y Growth Statistics
High Average Low
3023.07 %
211.08 %
-53.71 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 56
Sector # 233
S&P 500 # 1242




Other Revenue Growth
Medical Equipment & Supplies Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
CVRS's Revenue Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue jump for the quarter ending Jun 30 2019 within Healthcare SectorY/Y Change %Revenue for the quarter ending Jun 30 2019
Molecular Templates Inc 298.46%$ 298.464 millions
Zogenix Inc 293.78%$ 293.780 millions
Mannkind Corporation285.36%$ 285.358 millions
Dicerna Pharmaceuticals Inc 267.77%$ 267.767 millions
La Jolla Pharmaceutical Company258.00%$ 258.004 millions
Fresh Tracks Therapeutics Inc 250.07%$ 250.068 millions
Viskase Holdings inc 239.34%$ 239.344 millions
Collplant Biotechnologies Ltd232.97%$ 232.967 millions
Titan Medical Inc219.73%$ 219.734 millions
Vystar Corporation214.36%$ 214.359 millions
Zyla Life Sciences196.04%$ 196.037 millions
Precision Biosciences Inc187.57%$ 187.567 millions
Guardant Health Inc 178.48%$ 178.480 millions
Corindus Vascular Robotics, Inc.174.77%$ 174.775 millions
Fate Therapeutics Inc 174.29%$ 174.294 millions
Vbi Vaccines Inc173.50%$ 173.504 millions
Tandem Diabetes Care Inc 173.27%$ 173.267 millions
Seres Therapeutics Inc 171.70%$ 171.704 millions
Castle Biosciences Inc 169.89%$ 169.892 millions
Progenics Pharmaceuticals Inc156.99%$ 156.988 millions
Denali Therapeutics Inc 154.67%$ 154.672 millions
Biodelivery Sciences International Inc 143.75%$ 143.754 millions
Ainos Inc 142.40%$ 142.400 millions
Dyadic International Inc 142.33%$ 142.327 millions
Ontrak Inc 134.68%$ 134.678 millions
Principia Biopharma Inc 131.00%$ 131.000 millions
Scienture Holdings Inc 128.77%$ 128.774 millions
Geovax Labs Inc 125.10%$ 125.102 millions
Tivity Health Inc 124.13%$ 124.131 millions
Opiant Pharmaceuticals Inc 115.08%$ 115.079 millions


About Corindus Vascular Robotics, Revenue Growth Rates (CVRS), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: the company’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.